CRISTINA
JIMÉNEZ LUNA
CONTRATADA DE INVESTIGACIÓN POSTDOCTORAL
JOSÉ CARLOS
PRADOS SALAZAR
CATEDRÁTICO DE UNIVERSIDAD
Publicacions en què col·labora amb JOSÉ CARLOS PRADOS SALAZAR (28)
2023
-
Combining Olaparib and Ascorbic Acid on Nanoparticles to Enhance the Drug Toxic Effects in Pancreatic Cancer
International journal of nanomedicine, Vol. 18, pp. 5075-5093
-
Curso de anatomía de tórax y abdomen para estudiantes de Biociencias
Innovación docente e investigación en educación: nuevas tendencias para el cambio en la enseñanza superior (Dykinson), pp. 233-240
-
Evaluating Metabolite-Based Biomarkers for Early Diagnosis of Pancreatic Cancer: A Systematic Review
Metabolites, Vol. 13, Núm. 7
-
Serum nuclear magnetic resonance metabolomics analysis of human metastatic colorectal cancer: Biomarkers and pathway analysis
NMR in Biomedicine, Vol. 36, Núm. 9
2022
-
PARP1 inhibition by Olaparib reduces the lethality of pancreatic cancer cells and increases their sensitivity to Gemcitabine
Biomedicine and Pharmacotherapy, Vol. 155
2021
-
Circulating ptgs2, jag1, gucy2c and pgf mrna in peripheral blood and serum as potential biomarkers for patients with metastatic colon cancer
Journal of Clinical Medicine, Vol. 10, Núm. 11
-
Impact of the epigenetically regulated hoxa-5 gene in neural differentiation from human adipose-derived stem cells
Biology, Vol. 10, Núm. 8
-
Liquid biopsy approach to pancreatic cancer
World Journal of Gastrointestinal Oncology, Vol. 13, Núm. 10, pp. 1263-1287
-
Temozolomide: An updated overview of resistance mechanisms, nanotechnology advances and clinical applications
Current Neuropharmacology, Vol. 19, Núm. 4, pp. 513-537
-
Untargeted metabolomics for the diagnosis of exocrine pancreatic insufficiency in chronic pancreatitis
Medicina (Lithuania), Vol. 57, Núm. 9
2020
-
Differentiation of human mesenchymal stem cells towards neuronal lineage: Clinical trials in nervous system disorders
Biomolecules and Therapeutics, Vol. 28, Núm. 1, pp. 34-44
-
Discovery of pancreatic adenocarcinoma biomarkers by untargeted metabolomics
Cancers, Vol. 12, Núm. 4
-
MMR-proficient and MMR-deficient colorectal cancer cells: 5-Fluorouracil treatment response and correlation to CD133 and MGMT expression
Journal of Biosciences, Vol. 45, Núm. 1
-
Nanoparticles in Colorectal Cancer Therapy: Latest In Vivo Assays, Clinical Trials, and Patents
AAPS PharmSciTech, Vol. 21, Núm. 5
-
Novel biomarkers to distinguish between type 3c and type 2 diabetes mellitus by untargeted metabolomics
Metabolites, Vol. 10, Núm. 11, pp. 1-12
-
Role of exocrine and endocrine insufficiency in the management of patients with chronic pancreatitis
Journal of Clinical Medicine, Vol. 9, Núm. 6, pp. 1-12
-
State of the art in exocrine pancreatic insufficiency
Medicina (Lithuania), Vol. 56, Núm. 10, pp. 1-10
2019
-
The challenge of drug resistance in pancreatic ductal adenocarcinoma: a current overview
Cancer Biology and Medicine, Vol. 16, Núm. 4, pp. 688-699
-
Untargeted LC-HRMS-based metabolomics to identify novel biomarkers of metastatic colorectal cancer
Scientific Reports, Vol. 9, Núm. 1